News | Holy Young BioMedical Co., Ltd

N
E
W
S

最新消息橫幅

Holy Young BioMedical Co., Ltd. Signs Partnership Agreement with Lundoch Diagnostics AB (Sweden) to Promote AI-driven Diabetes Risk Prediction IVD Products (LDcoder) in Taiwan

Key Updates

February 05.2025

Holy Young BioMedical Co., Ltd. Signs Partnership Agreement with Lundoch Diagnostics AB (Sweden) to Promote AI-driven Diabetes Risk Prediction IVD Products (LDcoder) in Taiwan

Holy Young Co., Ltd. (hereinafter referred to as “Holy Young”) and Lundoch Diagnostics AB (hereinafter referred to as “Lundoch”) signed a market development partnership agreement on January 16, 2025. The collaboration aims to jointly promote the development and adoption of the AI-driven in vitro diagnostic

2023 Global Tuberculosis Summit

Key Updates

September 22.2023

2023 Global Tuberculosis Summit

2023 Global Tuberculosis Summit will take place from October 17-19. Our goal is to jointly advance TB prevention and control efforts, continue the fight against TB, and achieve significant progress and consensus

Holy Stone Healthcare Co., Ltd. and Professor Lior Rosenberg, co-founder of MediWound, jointly participated in the 2023 Taiwan Society for Burn Injuries and Wound Healing Annual Conference

Key Updates

September 05.2023

Holy Stone Healthcare Co., Ltd. and Professor Lior Rosenberg, co-founder of MediWound, jointly participated in the 2023 Taiwan Society for Burn Injuries and Wound Healing Annual Conference

The Taiwan Society for Burn Injuries and Wound Healing Annual Conference and Academic Symposium took place from September 2nd to September 3rd, 2023, at the Chung Shan Medical University Hospital. This year, Holy Stone Healthcare Co., Ltd. (4194.TW) (Holy Stone) invited Professor Lior Rosenberg, co-founder of MediWound

On 19th June 2023, the board of directors resolved the split-off and capital reduction of the businesses for agency dist

Corporate News

June 19.2023

On 19th June 2023, the board of directors resolved the split-off and capital reduction of the businesses for agency dist

On 19th June 2023, the board of directors resolved the split-off and capital reduction of the businesses for agency distribution in Taiwan and long-term equity investment.